Select date

April 2024
Mon Tue Wed Thu Fri Sat Sun

Chloroquine Is a Potent Inhibitor of SARS Coronavirus Infection and Spread

26-5-2021 < Global Research 11 384 words
 



All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version). 


Visit and follow us on Instagram at @crg_globalresearch.


***


This article was originally published on Virology Journal in 2005.


Abstract


Background


Severe acute respiratory syndrome (SARS) is caused by a newly discovered coronavirus (SARS-CoV). No effective prophylactic or post-exposure therapy is currently available.


Results


We report, however, that chloroquine has strong antiviral effects on SARS-CoV infection of primate cells. These inhibitory effects are observed when the cells are treated with the drug either before or after exposure to the virus, suggesting both prophylactic and therapeutic advantage. In addition to the well-known functions of chloroquine such as elevations of endosomal pH, the drug appears to interfere with terminal glycosylation of the cellular receptor, angiotensin-converting enzyme 2. This may negatively influence the virus-receptor binding and abrogate the infection, with further ramifications by the elevation of vesicular pH, resulting in the inhibition of infection and spread of SARS CoV at clinically admissible concentrations.


Conclusion


Chloroquine is effective in preventing the spread of SARS CoV in cell culture. Favorable inhibition of virus spread was observed when the cells were either treated with chloroquine prior to or after SARS CoV infection. In addition, the indirect immunofluorescence assay described herein represents a simple and rapid method for screening SARS-CoV antiviral compounds.


Read the full article here.


*


Note to readers: Please click the share buttons above or below. Follow us on Instagram, @crg_globalresearch. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.


Full authors


Martin J VincentEric BergeronSuzanne BenjannetBobbie R EricksonPierre E RollinThomas G KsiazekNabil G SeidahStuart T Nichol


Featured image is from InfoBrics



Print